Chong-Sheng Chen

447 total citations
10 papers, 362 citations indexed

About

Chong-Sheng Chen is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Chong-Sheng Chen has authored 10 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in Chong-Sheng Chen's work include Pharmacogenetics and Drug Metabolism (3 papers), Cancer Research and Treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Chong-Sheng Chen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Cancer Research and Treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Chong-Sheng Chen collaborates with scholars based in United States, China and Canada. Chong-Sheng Chen's co-authors include David J. Waxman, Youssef Jounaïdi, Pamela S. Schwartz, James R. Halpert, Kendrick A. Goss, Jack T. Lin, You-Ai He, Ekaterina V. Laz, Todd Blute and Jie Ma and has published in prestigious journals such as Cancer Research, Endocrinology and Molecular Pharmacology.

In The Last Decade

Chong-Sheng Chen

10 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chong-Sheng Chen United States	9	187	113	98	61	57	10	362
Nona Rama United Kingdom	12	255 1.4×	108 1.0×	48 0.5×	81 1.3×	29 0.5×	17	534
Munindra Ruwali India	13	277 1.5×	58 0.5×	84 0.9×	60 1.0×	29 0.5×	22	416
Mingen Lin China	8	202 1.1×	178 1.6×	135 1.4×	58 1.0×	16 0.3×	18	473
Olga V. Trubetskoy United States	10	221 1.2×	67 0.6×	137 1.4×	47 0.8×	36 0.6×	12	393
Janet Ward United Kingdom	7	144 0.8×	197 1.7×	28 0.3×	89 1.5×	63 1.1×	8	419
C. Gaggini Italy	9	154 0.8×	109 1.0×	27 0.3×	29 0.5×	69 1.2×	13	352
S. Naito Japan	8	134 0.7×	85 0.8×	75 0.8×	26 0.4×	44 0.8×	16	362
Sonam Tulsyan India	15	283 1.5×	218 1.9×	81 0.8×	96 1.6×	53 0.9×	24	600
Agnès Basseville United States	11	321 1.7×	239 2.1×	35 0.4×	56 0.9×	30 0.5×	18	521

Countries citing papers authored by Chong-Sheng Chen

Since Specialization

Citations

This map shows the geographic impact of Chong-Sheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong-Sheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong-Sheng Chen more than expected).

Fields of papers citing papers by Chong-Sheng Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong-Sheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong-Sheng Chen. The network helps show where Chong-Sheng Chen may publish in the future.

Co-authorship network of co-authors of Chong-Sheng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chong-Sheng Chen. A scholar is included among the top collaborators of Chong-Sheng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong-Sheng Chen. Chong-Sheng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Ma, Jie, Chong-Sheng Chen, Todd Blute, & David J. Waxman. (2011). Antiangiogenesis Enhances Intratumoral Drug Retention. Cancer Research. 71(7). 2675–2685. 42 indexed citations

Laz, Ekaterina V., et al.. (2007). Characterization of Three Growth Hormone-Responsive Transcription Factors Preferentially Expressed in Adult Female Liver. Endocrinology. 148(7). 3327–3337. 48 indexed citations

Jounaïdi, Youssef, Chong-Sheng Chen, Gareth J. Veal, & David J. Waxman. (2006). Enhanced antitumor activity of P450 prodrug-based gene therapy using the low Km cyclophosphamide 4-hydroxylase P450 2B11. Molecular Cancer Therapeutics. 5(3). 541–555. 31 indexed citations

Riddick, David S., Chunja Lee, Edwin C. Chinje, et al.. (2005). CANCER CHEMOTHERAPY AND DRUG METABOLISM. Drug Metabolism and Disposition. 33(8). 1083–1096. 57 indexed citations

Chen, Chong-Sheng, Youssef Jounaïdi, & David J. Waxman. (2005). ENANTIOSELECTIVE METABOLISM AND CYTOTOXICITY OF R-IFOSFAMIDE AND S-IFOSFAMIDE BY TUMOR CELL-EXPRESSED CYTOCHROMES P450. Drug Metabolism and Disposition. 33(9). 1261–1267. 40 indexed citations

Chen, Chong-Sheng, Jack T. Lin, Kendrick A. Goss, et al.. (2004). Activation of the Anticancer Prodrugs Cyclophosphamide and Ifosfamide: Identification of Cytochrome P450 2B Enzymes and Site-Specific Mutants with Improved Enzyme Kinetics. Molecular Pharmacology. 65(5). 1278–1285. 83 indexed citations

Schwartz, Pamela S., Chong-Sheng Chen, & David J. Waxman. (2003). Sustained P450 expression and prodrug activation in bolus cyclophosphamide-treated cultured tumor cells. Impact of prodrug schedule on P450 gene-directed enzyme prodrug therapy. Cancer Gene Therapy. 10(8). 571–582. 17 indexed citations

Schwartz, Pamela S., Chong-Sheng Chen, & David J. Waxman. (2002). Enhanced bystander cytotoxicity of P450 gene-directed enzyme prodrug therapy by expression of the antiapoptotic factor p35.. PubMed. 62(23). 6928–37. 22 indexed citations

Deng, Dajun, et al.. (1991). Mutagenicity and carcinogenicity of fish sauce from a county with the high risk for gastric cancer in china. Chinese Journal of Cancer Research. 3(1). 18–23. 5 indexed citations

10.

Pignatelli, Brigitte, et al.. (1989). Group-selective determination of total N-nitroso compounds in nitrate-containing human urine samples. The Analyst. 114(9). 1103–1103. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact